Researchers believe that gastrointestinal disorders may be linked to the brain dysfunctions that cause autism. Recent studies have shown that there are beneficial effects of enzyme-based therapy for Autism spectrum disorders.
In a study conducted by Dr. Timothy Buie, a pediatric gastroenterologist from Harvard/Mass General hospital, forty-six patients between the ages of 5 and 31 were selected for inclusion in a study based on a diagnosis placing them in the category of the Autism spectrum disorders, ADD and ADHD. Their diets were supplemented with a dietary enzyme formulation. The results: the enzyme formula beneficially and safely affected all thirteen of the parameters measured; improvements ranged from 50-90% depending on the parameters. The enzyme was effective at improving the symptoms such as socialization, hyperactivity, attention, eye contact, comprehension and compulsions.
For both ADD/ADHD and Autism, stimulation of the limbic region of the brain may also help treat these disorders. The aromas from therapeutic essential oils have a powerful ability to stimulate this part of the brain, since the sense of smell is tied directly to the mind’s emotional and hormonal centers. As a result, the aroma of an essential oil has the potential to exert a powerful influence on ADD/ADHD and Autism.
In a two-year case study (1999-2001), Dr. Terry Friedmann, M.D., found significant results when children that had previously been diagnosed with ADD/ADHD were administered therapeutic essential oils by inhalation.
The essential oils Vetiver, Lavender, and Cedarwood were used.
The oils were administered in this fashion: one oil was administered by inhalation three times per day for 30 days. An inhalation device was also used at night to administer a continuous inhalation of oil.
The inhalation of the oils proved to settle the children’s brain waves back into normal patterns and improved their scholastic performance and behavioral patterns.
The final results:
Lavender increased performance by 53%.
Cedarwood increased performance by 83%.
Vetiver increased performance by 100%.
This study will be published in the American Medical Association Journal.